Literature DB >> 27155944

Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.

C S Abboud1, J Monteiro2, M E Stryjewski3, E C Zandonadi4, V Barbosa4, D Dantas4, E E Sousa4, M J Fonseca5, D M Jacobs6, A C Pignatari5, C Kiffer5, G G Rao6.   

Abstract

Invasive infections due to carbapenem-resistant Enterobacteriaceae (CRE), including polymyxin-resistant (PR-CRE) strains, are being increasingly reported. However, there is a lack of clinical data for several life-threatening infections. Here we describe a cohort of patients with post-surgical mediastinitis due to CRE, including PR-CRE. This study was a retrospective cohort design at a single cardiology centre. Patients with mediastinitis due to CRE were identified and were investigated for clinically relevant variables. Infecting isolates were studied using molecular techniques. Patients infected with polymyxin-susceptible CRE (PS-CRE) strains were compared with those infected with PR-CRE strains. In total, 33 patients with CRE mediastinitis were studied, including 15 patients (45%) with PR-CRE. The majority (61%) were previously colonised. All infecting isolates carried blaKPC genes. Baseline characteristics of patients with PR-CRE mediastinitis were comparable with those with PS-CRE mediastinitis. Of the patients studied, 70% received at least one agent considered active in vitro and most patients received at least three concomitant antibiotics. Carbapenem plus polymyxin B was the most common antibiotic combination (73%). Over 90% of patients underwent surgical debridement. Overall, in-hospital mortality was 33% and tended to be higher in patients infected with PR-CRE (17% vs. 53%; P=0.06). In conclusion, mediastinitis due to CRE, including PR-CRE, can become a significant challenge in centres with CRE and a high cardiac surgery volume. Despite complex antibiotic treatments and aggressive surgical procedures, these patients have a high mortality, particularly those infected with PR-CRE.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae; Mediastinitis; Polymyxin resistance; Post-surgical infection

Mesh:

Substances:

Year:  2016        PMID: 27155944     DOI: 10.1016/j.ijantimicag.2016.02.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

1.  In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae.

Authors:  Dennis Huang; Brenda Yu; John K Diep; Rajnikant Sharma; Michael Dudley; Jussimara Monteiro; Keith S Kaye; Jason M Pogue; Cely Saad Abboud; Gauri G Rao
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 2.  Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.

Authors:  David M Jacobs; M Courtney Safir; Dennis Huang; Faisal Minhaj; Adam Parker; Gauri G Rao
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-25       Impact factor: 3.944

3.  A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Authors:  Oryan Henig; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Steve Marshall; Susan D Rudin; T Nicholas Domitrovic; Andrea M Hujer; Kristine M Hujer; Yohei Doi; Scott Evans; Vance G Fowler; Robert A Bonomo; David van Duin; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2017-07-27       Impact factor: 3.835

4.  Pancreatic enzymatic mediastinitis followed by total gastrectomy with splenectomy: report of two cases.

Authors:  Yoko Zaitsu; Takashi Nishizaki; Takuma Izumi; Daisuke Taniguchi; Yuichiro Kajiwara; Yumi Oshiro; Kazuhito Minami
Journal:  Surg Case Rep       Date:  2021-06-27

5.  Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis.

Authors:  Cely Saad Abboud; Gauri G Rao; Ercilia E Souza; Alexandre P Zavascki; Carlos Kiffer
Journal:  Braz J Infect Dis       Date:  2017-11-26       Impact factor: 3.257

6.  Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years.

Authors:  Flávia Rossi; Raquel Girardello; Ana Paula Cury; Thais Sabato Romano Di Gioia; João Nóbrega de Almeida; Alberto José da Silva Duarte
Journal:  Braz J Infect Dis       Date:  2016-11-08       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.